Montillo M - Search Results

1

Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion.

Nosari A, Oreste P, Cairoli R, Montillo M, Carrafiello G, Astolfi A, Muti G, Marbello L, Tedeschi A, Magliano E, Morra E. Nosari A, et al. Among authors: montillo m. Am J Hematol. 2001 Dec;68(4):231-6. doi: 10.1002/ajh.1187. Am J Hematol. 2001. PMID: 11754411 Free article.

2

Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies.

Nosari A, Anghilieri M, Carrafiello G, Guffanti C, Marbello L, Montillo M, Muti G, Ribera S, Vanzulli A, Nichelatti M, Morra E. Nosari A, et al. Among authors: montillo m. Haematologica. 2003 Dec;88(12):1405-9. Haematologica. 2003. PMID: 14687995 Free article.

3

'Use it again!': retherapy with bendamustine in indolent B-cell lymphoproliferative disorders.

Montillo M, Tedeschi A. Montillo M, et al. Expert Rev Hematol. 2013 Jun;6(3):247-50. doi: 10.1586/ehm.13.26. Expert Rev Hematol. 2013. PMID: 23782078

4

Mucormycosis in hematologic malignancies: an emerging fungal infection.

Nosari A, Oreste P, Montillo M, Carrafiello G, Draisci M, Muti G, Molteni A, Morra E. Nosari A, et al. Among authors: montillo m. Haematologica. 2000 Oct;85(10):1068-71. Haematologica. 2000. PMID: 11025599 Free article.

5

Prior invasive pulmonary and cerebellar mucormycosis is not a primary contraindication to perform an autologous stem cell transplatation in leukemia.

Tedeschi A, Montillo M, Cairoli R, Marenco P, Cafro A, Oreste P, Nosari A, Morra E. Tedeschi A, et al. Among authors: montillo m. Leuk Lymphoma. 2002 Mar;43(3):657-9. doi: 10.1080/10428190290012236. Leuk Lymphoma. 2002. PMID: 12002776

6

Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.

Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E; Cooperative Study Group on PTLDs. Muti G, et al. Among authors: montillo m. Haematologica. 2002 Jan;87(1):67-77. Haematologica. 2002. PMID: 11801467

7

Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine.

Montillo M, Cafro AM, Tedeschi A, Brando B, Oreste P, Veronese S, Rossi V, Cairoli R, Pungolino E, Morra E. Montillo M, et al. Haematologica. 2002 Jul;87(7):695-700; discussion 700. Haematologica. 2002. PMID: 12091119 Clinical Trial.

8

Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.

Montillo M, Tedeschi A, O'Brien S, Di Raimondo F, Lerner S, Ferrajoli A, Morra E, Keating MJ. Montillo M, et al. Cancer. 2003 Jan 1;97(1):114-20. doi: 10.1002/cncr.11000. Cancer. 2003. PMID: 12491512 Free article. Clinical Trial.

9

Role of fludarabine in hematological malignancies.

Montillo M, Ricci F, Tedeschi A. Montillo M, et al. Expert Rev Anticancer Ther. 2006 Sep;6(9):1141-61. doi: 10.1586/14737140.6.9.1141. Expert Rev Anticancer Ther. 2006. PMID: 17020450 Review.

10

Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.

Montillo M, Ricci F, Tedeschi A, Cafro AM, Nosari AM, Nichelatti M, Marbello L, Morra E. Montillo M, et al. Leuk Res. 2009 Aug;33(8):1072-8. doi: 10.1016/j.leukres.2008.12.014. Epub 2009 Feb 1. Leuk Res. 2009. PMID: 19187960 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters